Testing effectiveness (Phase 2)WithdrawnNCT03026231
What this trial is testing
Characterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease Patients
Who this might be right for
Parkinson's Disease
The University of Texas Health Science Center, Houston